ACTRN12622001332718招募中未知
stekinumab as Induction and Maintenance Therapy for Ulcerative Colitis Extension Discovery on their clinical outcomes
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients who participated in the UNIFI study (NCT02407236 , DOI: 10.1056/NEJMoa1900750) from Australian sites, and who persisted on ustekimumab therapy as maintenance treatment for their ulcerative colitis
排除标准
- •Patients with no relevant data
研究者
相似试验
进行中（未招募）
1 期
sTekinumab for the treatment Of Patients with active Ankylosing SpondylitisEUCTR2011-000844-56-DECharité Universitätsmedizin Berlin20
已完成
不适用
Effectiveness of Ustekinumab in Induction and Maintenance Therapy of ulcerative colitis (RUN-UC)K51Ulcerative colitisDRKS00022043CED Service GmbH507
进行中（未招募）
1 期
Single-agent rituximab as maintenance treatment versus observation after combined induction immunochemotherapy with fludarabine, cyclophosphamide and rituximab (FCR) in patients older than 65 years with previously untreated B-cell chronic lymphocytic leukemia (B-CLL): a phase III intergroup trial of the GOELAMS and the FCGCLL/WM groups. - LLC 2007 SAEUCTR2007-001015-28-FRCHU TOURS304
招募中
3 期
Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary EmbolismPulmonary EmbolismNCT06362746Supergene, LLC486
已完成
不适用
Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s DiseaseK50Crohn disease [regional enteritis]DRKS00011811CED Service GmbH901